整合贝叶斯方法和专家知识,预测2型糖尿病中持续葡萄糖监测值的预测
IEEE journal of biomedical and health informatics
|October 1, 2024
概括
这项研究开发了一种用于预测2型糖尿病患者血糖水平的新系统. 它将专家知识与数据驱动模型集成为个性化糖尿病管理.
科学领域:
- 内分泌学和新陈代谢学
- 生物医学信息学 生物医学信息学
- 在医疗保健中的数据科学.
背景情况:
- 2型糖尿病 (T2DM) 管理需要精确的血糖预测,因为它的异质性质.
- 现有的预测系统往往缺乏针对T2DM独特挑战的专业化.
- 上海T2DM数据集为开发定制的T2DM管理工具提供了宝贵的资源.
研究的目的:
- 专门为2型糖尿病患者 (T2DM) 引入一种新的血糖预测系统.
- 整合知识驱动和数据驱动的方法,以提高预测准确度.
- 为个性化糖尿病管理策略建立一个框架.
主要方法:
- 利用贝叶斯网络方法分析糖尿病相关变量之间的依赖关系.
- 采用贝叶斯结构时间序列 (BSTS) 模型进行葡萄糖水平预测.
- 集成的持续血糖监测 (CGM) 数据,饮食记录和患者特定信息.
主要成果:
- 该BSTS模型准确地预测了从15到60分钟前的葡萄糖水平.
- 在15分钟的预测中,获得了[插入值] mg/dL的平均绝对误差和[插入值] mg/dL的根平均平方误差.
- 证明了上海T2DM数据集的首次应用,用于预测血糖,考虑与糖尿病相关的变量.
结论:
- 开发的系统为T2DM中个性化糖尿病管理提供了基础框架.
- 准确和及时的葡萄糖预测有可能提高糖尿病护理干预措施.
- 将专家知识与数据驱动模型集成为T2DM管理提供了一个有希望的方法.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Management and Pharmacotherapy
243
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243
Carbohydrate Metabolism
10.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.8K
Pathophysiology of Diabetes
894
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
894
Hypoglycemia and Glucagon
206
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
206


